Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 21, 2010PLoS ONEOpen Access

Safety and Immunogenicity Study of Multiclade HIV-1 Adenoviral Vector Vaccine Alone or as Boost following a Multiclade HIV-1 DNA Vaccine in Africa

View Full Paper
Ask AI
Bookmark
Share

Authors

WJWalter JaokoUniversity of NairobiEKEtienne KaritaRwanda Biomedical CenterKKKayitesi KayitenkoreAdventist University of Central Africa

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Jaoko et al. (2010) studied this question.

synapsesocial.com/papers/6a8506e2abaf849ca59df091https://doi.org/10.1371/journal.pone.0012873
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Rapid evolution of the neutralizing antibody response to HIV type 1 infection2003 · 1,224 citations
  2. 2Priming Immunization with DNA Augments Immunogenicity of Recombinant Adenoviral Vectors for Both HIV-1 Specific Antibody and T-Cell Responses2010 · 134 citations
  3. 3Concordant Proficiency in Measurement of T-Cell Immunity in Human Immunodeficiency Virus Vaccine Clinical Trials by Peripheral Blood Mononuclear Cell and Enzyme-Linked Immunospot Assays in Laboratories from Three Continents2008 · 60 citations
  4. 4Comparative Seroprevalence and Immunogenicity of Six Rare Serotype Recombinant Adenovirus Vaccine Vectors from Subgroups B and D2007 · 524 citations
  5. 5Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand2009 · 3,076 citations